Ocular TherapeutixOCUL

那斯達克 · USD
8.25
-0.55
(-6.25%)
收盤 06/06 03:59 (UTC+8)
盤後 
8.26 
+0.01 
(+0.12%)
06/06 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.15
  • 0.15
  • 0.16
  • 0.15
  • 0.17
  • 0.11
  • 0.13
  • 0.15
  • 0.13
  • 0.11
icon
  • -1.86
  • -0.18
  • 11.28
  • -6.17
  • 10.74
  • -37.37
  • 25.80
  • 8.08
  • -8.90
  • -18.60
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
10,785
13,250
14,545
13,458
10,698
17,082
15,426
16,441
14,774
14,801
營業成本
1,3291,5941,7741,9441,2621,2301,5611,5091,3261,386
營業毛利
9,456
11,656
12,771
11,514
9,436
15,852
13,865
14,932
13,448
13,415
營業費用
102,79681,41681,46979,15673,353-59,863-45,06533,465
研發費用
66,21350,80052,35851,08142,85740,98937,05428,85720,73516,195
推銷及管理費用
36,58330,61629,11128,07530,49625,43922,80929,66524,33017,270
非經常性項目費用
----------
其他營業費用
----------
營業利益
-93,340
-69,760
-68,698
-67,642
-63,917
-50,576
-45,998
-43,590
-31,617
-20,050
其他收入及費用
7,5057,9382,2832,8442,8485,29412,7293,009-29,180-5,019
利息費用
2,7772,8323,0033,0162,9843,1063,2243,1964,0514,151
稅前純益
-88,612
-64,654
-69,418
-67,814
-64,053
-48,388
-36,493
-43,777
-64,848
-29,220
所得稅
----------
稅後純益
-88,612
-64,654
-69,418
-67,814
-64,053
-48,388
-36,493
-43,777
-64,848
-29,220
基本每股稅後盈餘(元)
-0.40-0.29-0.38-0.39-0.38-0.29-0.22-0.26-0.49-
稀釋每股稅後盈餘(元)
-0.40-0.27-0.38-0.39-0.38-0.28-0.21-0.24-0.49-0.25
基本平均股數(千股)
224099.00222921.00183919.00172594.00169396.00168019.00166992.00165824.00132021.00-
稀釋平均股數(千股)
224099.00222921.00183919.00172594.00169396.00168019.00166992.00165824.00132021.00-
還原基本每股稅後盈餘(元)
-0.40-0.29-0.38-0.39-0.38-0.29-0.22-0.26-0.49-
還原稀釋每股稅後盈餘(元)
-0.40-0.27-0.38-0.39-0.38-0.28-0.21-0.24-0.49-0.25
還原基本平均股數(千股)
224,099222,921183,919172,594169,396168,019166,992165,824132,021-
還原稀釋平均股數(千股)
224,099222,921183,919172,594169,396168,019166,992165,824132,021-
EBITDA(千元)
-84,552-60,575-65,346-63,772-60,088-44,331-32,310-39,625-59,877-24,111

大家都在看

HOT